Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Combined treatment for smoking cessation, anxiety and depression more effective than smoking cessation alone

A randomised control trial published in The Journal of Acquired Immune Deficiency Syndromes by researchers in Boston found that an integrated cognitive-behavioural treatment approach aiming to target

Published
17 October 2018
By
Krishen Samuel
South Africa: Shortage of HIV/Aids drugs turning into ‘national crisis’

ARVs and contraceptives have run out across the country in ‘a crisis that has been developing over the past two months’, the Stop Stockout Project claims.

Published
16 October 2018
From
The Citizen
Rapid Initiation of HIV Care: Assessing Safety and Efficacy

Discussion with Gregory Huhn, MD

Published
16 October 2018
From
Infectious Disease Advisor
Canada to invest $8.5 million in harm reduction projects for HCV, HIV

Canadian Minister of Health announced that the Government of Canada will fund 28 projects across the country designed to reduce the risk for bloodborne infections among people who use injection drugs such as hepatitis C and HIV, according to a press release.

Published
16 October 2018
From
Healio
Tuberculosis rates in England hit lowest recorded levels

New data released by Public Health England reveal that the number of people diagnosed with tuberculosis In England is at its lowest level since the 1990s.

Published
16 October 2018
From
Public Health England
Internet-based intervention effective in the treatment of depression in people living with HIV

An online self-help intervention is effective in the treatment of mild to moderate depressive symptoms in people with HIV, according to a randomised clinical trial conducted in the

Published
16 October 2018
By
Alain Volny-Anne
Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV

The direct-acting antiviral Vosevi demonstrated an average sustained virologic response rate of 87% among patients who were “triple-infected” with hepatitis C genotype 3, hepatitis B and HIV, as presented at the American College of Gastroenterology Annual Meeting.

Published
15 October 2018
From
Healio
Adolescents and HIV: kindness and time key factors for treatment retention

New research from South Africa provides insights into the factors associated with retention of adolescents in HIV care, suggesting relatively low‐cost interventions could significantly improve adherence and retention in care.

Published
15 October 2018
From
AVERT
Wide range of views about switching to weekly, monthly or biannual ART

Two-thirds of people taking combination antiretroviral therapy (cART) would be interested in switching to a once-weekly oral regimen should it become available, according to American research published in

Published
15 October 2018
By
Michael Carter
Anal HPV-16 infection significantly more common in men who have sex with men, especially those living with HIV

Anal infection with HPV-16, the type of human papillomavirus most strongly associated with anal cancer, is most common in HIV-positive gay men, similar between HIV-negative gay

Published
15 October 2018
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.